Versant Capital Management’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23 | Hold |
15
| – | – | ﹤0.01% | 2625 |
|
|
2025
Q1 | $18 | Hold |
15
| – | – | ﹤0.01% | 2507 |
|
|
2024
Q4 | $47 | Hold |
15
| – | – | ﹤0.01% | 2366 |
|
|
2024
Q3 | $42 | Hold |
15
| – | – | ﹤0.01% | 1996 |
|
|
2024
Q2 | $81 | Hold |
15
| – | – | ﹤0.01% | 1936 |
|
|
2024
Q1 | $65 | Hold |
15
| – | – | ﹤0.01% | 1867 |
|
|
2023
Q4 | $83 | Hold |
15
| – | – | ﹤0.01% | 1900 |
|
|
2023
Q3 | $68 | Hold |
15
| – | – | ﹤0.01% | 1930 |
|
|
2023
Q2 | $47 | Hold |
15
| – | – | ﹤0.01% | 2039 |
|
|
2023
Q1 | $11 | Hold |
15
| – | – | ﹤0.01% | 1766 |
|
|
2022
Q4 | $40 | Hold |
15
| – | – | ﹤0.01% | 1645 |
|
|
2022
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 1564 |
|
|
2022
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 1567 |
|
|
2022
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 1566 |
|
|
2021
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 1535 |
|
|
2021
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 1540 |
|
|
2021
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 1540 |
|